Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen for congenital fibrinogen deficiency
CTR20181256Phase 3Completed
- Sponsor
- Pacific Shuanglin Bio-pharmacy
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital hypofibrinogenemia, sponsored by Pacific Shuanglin Bio-pharmacy. Started Aug 2018; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiencycongenital hypofibrinogenemia
Beyond the preview
Go deeper on CTR20181256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181256.